Eiko Namba

Potent In Vitro Activity of Tomopenem (CS-023) against Methicillin-Resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>

Tetsufumi Koga, Nobuhisa Masuda, Masayo Kakuta et al. · Antimicrobial Agents and Chemotherapy · 2008 · 33 citations · Full text

Antibacterial Activity, Antimicrobial Chemotherapy, Drug Resistance +16

<i>In Vivo</i> Pharmacodynamic Activity of Tomopenem (formerly CS-023) against <i>Pseudomonas aeruginosa</i> and Methicillin-Resistant <i>Staphylococcus aureus</i> in a Murine Thigh Infection Model

Kiyoshi Sugihara, Chika Sugihara, Yoko Matsushita et al. · Antimicrobial Agents and Chemotherapy · 2010 · 24 citations

Against Mrsa, Antimicrobial Chemotherapy, Bacterial Pathogens +20

<i>In Vitro</i> and <i>In Vivo</i> Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus

Tarani Kanta Barman, Manoj Kumar, Tarun Mathur et al. · Antimicrobial Agents and Chemotherapy · 2018 · 15 citations · Full text

Affinity of Tomopenem (CS-023) for Penicillin-Binding Proteins in <i>Staphylococcus aureus</i> , <i>Escherichia coli</i> , and <i>Pseudomonas aeruginosa</i>

Tetsufumi Koga, Chika Sugihara, Masayo Kakuta et al. · Antimicrobial Agents and Chemotherapy · 2008 · 13 citations · Full text

Bacteriology, Molecular Biology, Escherichia Coli +20

Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists

Masayoshi Asano, Tsuyoshi Nakamura, Yukiko Sekiguchi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 10 citations · Full text